These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22846417)

  • 1. Primary care trusts reverse advice to ophthalmologists to use cheaper drug for wet age related macular degeneration.
    Hawkes N
    BMJ; 2012 Jul; 345():e5161. PubMed ID: 22846417
    [No Abstract]   [Full Text] [Related]  

  • 2. Novartis takes legal action over trusts' advice to use bevacizumab for wet AMD.
    Torjesen I
    BMJ; 2012 Apr; 344():e2959. PubMed ID: 22532011
    [No Abstract]   [Full Text] [Related]  

  • 3. Why have UK doctors been deterred from prescribing Avastin?
    Cohen D
    BMJ; 2015 Apr; 350():h1654. PubMed ID: 25834024
    [No Abstract]   [Full Text] [Related]  

  • 4. A licence to cure.
    Aronson JK; Ferner RE
    BMJ; 2015 Apr; 350():h1723. PubMed ID: 25834026
    [No Abstract]   [Full Text] [Related]  

  • 5. Why using Avastin for eye disease is so difficult.
    Torjesen I
    BMJ; 2012 May; 344():e3012. PubMed ID: 22549057
    [No Abstract]   [Full Text] [Related]  

  • 6. A clearer view of evidence in treating macular degeneration: off-label policies and independent research.
    Formoso G; Marata AM; Magrini N; Bero L
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):ED000090. PubMed ID: 25228121
    [No Abstract]   [Full Text] [Related]  

  • 7. Roche and Novartis colluded over wet AMD drugs, says Italian regulator.
    Cohen D
    BMJ; 2014 Mar; 348():g2006. PubMed ID: 24615827
    [No Abstract]   [Full Text] [Related]  

  • 8. Avastin and Lucentis: a guide through the legal maze.
    Lock D
    BMJ; 2015 Apr; 350():h1377. PubMed ID: 25834023
    [No Abstract]   [Full Text] [Related]  

  • 9. CCGs face legal threat for offering off-label drug for wet AMD.
    Cohen D
    BMJ; 2017 Oct; 359():j5021. PubMed ID: 29089307
    [No Abstract]   [Full Text] [Related]  

  • 10. Attacks on publicly funded trials: what happens when industry does not want to know the answer.
    Cohen D
    BMJ; 2015 Apr; 350():h1701. PubMed ID: 25834025
    [No Abstract]   [Full Text] [Related]  

  • 11. Avastin is as effective as Lucentis in treating wet age related macular degeneration, study finds.
    Torjesen I
    BMJ; 2013 Jul; 347():f4678. PubMed ID: 23881948
    [No Abstract]   [Full Text] [Related]  

  • 12. Cheaper alternative for macular degeneration is as safe as licensed drug, review finds.
    Kmietowicz Z
    BMJ; 2014 Sep; 349():g5618. PubMed ID: 25224545
    [No Abstract]   [Full Text] [Related]  

  • 13. Legal. PCTs taken to court over use of cheaper drug.
    Calkin S
    Health Serv J; 2012 Apr; 122(6303):10-1. PubMed ID: 22741353
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal antibodies: magic bullets with a hefty price tag.
    Shaughnessy AF
    BMJ; 2012 Dec; 345():e8346. PubMed ID: 23236036
    [No Abstract]   [Full Text] [Related]  

  • 15. Perhaps the Avastin debate should be resolved in court.
    Fell G
    BMJ; 2015 Apr; 350():h2044. PubMed ID: 25901019
    [No Abstract]   [Full Text] [Related]  

  • 16. The GMC's stance on Avastin.
    Dickson N
    BMJ; 2015 Apr; 350():h2043. PubMed ID: 25898987
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of "not me" drugs for health systems: lessons from age related macular degeneration.
    Campbell RJ; Dhalla IA; Gill SS; Bell CM
    BMJ; 2012 May; 344():e2941. PubMed ID: 22549055
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost comparison of ranibizumab and bevacizumab.
    Jackson TL; Kirkpatrick L
    BMJ; 2011 Aug; 343():d5058. PubMed ID: 21862536
    [No Abstract]   [Full Text] [Related]  

  • 19. Age-related macular degeneration, anti-VEGF therapy, and ophthalmic imaging: is there a best practice?
    Han DP
    JAMA Ophthalmol; 2013 Sep; 131(9):1124-6. PubMed ID: 23744293
    [No Abstract]   [Full Text] [Related]  

  • 20. [Age-related visual loss].
    Neubauer AS; Kernt M
    MMW Fortschr Med; 2013 Feb; 155(2):36-7. PubMed ID: 23573743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.